World

Illumina collaborates with Nashville Biosciences to accelerate medicines development

 Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

 January 11, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

 Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

 January 05, 2022 | News

5 Ways to Help Reduce the Risk of Birth Defects

Each year, birth defects affect about 1 in 33 babies born in the United States, according to the U.S. Centers for Disease Control and Prev...

 January 04, 2022 | News

World's first automated 24/7 blood pressure monitor comes to the USA

Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is bringing its 24/7 Blood Pressure Monitor to&nb...

 January 04, 2022 | News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

 January 03, 2022 | News

WHO SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Li...

 December 22, 2021 | News

WHO Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization ...

 December 10, 2021 | News

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executiv...

 December 09, 2021 | News

BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease

- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease por...

 December 03, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

 November 05, 2021 | News

New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA

The TCI in Taiwan announced that its "Banana Peel, Banana Stamen" has received the FDA's new dietary supplement ingredient NDI safety response, a...

 November 02, 2021 | News

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Solution enables manufacturers to optimize manufacturing capacity, quality, efficiency and scalability 3M Separation and Purification Sciences announ...

 November 01, 2021 | News

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

 October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Abcam Completes $340m strategic acquisition of BioVision

Abcam , a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expa...

 October 28, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close